Bell Investment Advisors »

Verve Therapeutics shares owned by Bell Investment Advisors

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Bell Investment Advisors from 13F filings

Historical chart of Bell Investment Advisors investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Bell Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Bell Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $586 42 13.95

More positions owned by Bell Investment Advisors

Goldman Sachs Etf Tr Acces Treasury (GBIL)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Flexshares Tr Iboxx 3r Targt (TDTT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Schwab Strategic Tr Schwab Fdt Us Sc (FNDA)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Ishares Tr Msci Usa Mmentm (MTUM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Bell Investment Advisors

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics